Search by Drug Name or NDC

NDC 42291-0024-12 Abiraterone Acetate 250 mg/1 Details

Abiraterone Acetate 250 mg/1

Abiraterone Acetate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvKARE. The primary component is ABIRATERONE ACETATE.

MedlinePlus Drug Summary

Abiraterone is used in combination with prednisone to treat a certain type of prostate cancer that has spread to other parts of the body. Abiraterone is in a class of medications called androgen biosynthesis inhibitors. It works by decreasing the amount of certain hormones in the body.

Related Packages: 42291-0024-12
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Abiraterone

Product Information

NDC	42291-0024
Product ID	42291-024_0e8b3606-7e08-af78-e063-6294a90afbd2
Associated GPIs	21406010200320
GCN Sequence Number	067349
GCN Sequence Number Description	abiraterone acetate TABLET 250 MG ORAL
HIC3	V1J
HIC3 Description	ANTINEOPLASTIC - ANTIANDROGENIC AGENTS
GCN	29886
HICL Sequence Number	037571
HICL Sequence Number Description	ABIRATERONE ACETATE
Brand/Generic	Generic
Proprietary Name	Abiraterone Acetate
Proprietary Name Suffix	n/a
Non-Proprietary Name	Abiraterone
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	250
Active Ingredient Units	mg/1
Substance Name	ABIRATERONE ACETATE
Labeler Name	AvKARE
Pharmaceutical Class	Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA208327
Listing Certified Through	2025-12-31

Package

NDC 42291-0024-12 (42291002412)

Pricing Information	N/A
NDC Package Code	42291-024-12
Billing NDC	42291002412
Package	120 TABLET in 1 BOTTLE (42291-024-12)
Marketing Start Date	2019-01-14
NDC Exclude Flag	N